Current Assets
Finished goods
Eli Lilly Finished goods increased by 17.7% to $2.27B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 75.1%, from $1.30B to $2.27B. Over 2 years (FY 2023 to FY 2025), Finished goods shows an upward trend with a 56.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2023
Last reportedQ1 2026Apr 30, 2026
Parent metricInventories
How to read this metric
An increase relative to sales may signal slowing demand or overproduction; a decrease may indicate strong sales or supply chain constraints.
Detailed definition
This represents the value of inventory that has completed the manufacturing process and is ready for sale to customers....
Peer comparison
Standard inventory metric for all manufacturing and retail companies.
Metric ID:
inv_finished_goodsHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $791.70M | $699.60M | $811.10M | $1.11B | $1.22B | $1.30B | $1.35B | $1.55B | $1.93B | $2.27B |
| QoQ Change | — | -11.6% | +15.9% | +37.3% | +9.6% | +6.3% | +4.4% | +14.2% | +24.8% | +17.7% |
| YoY Change | — | — | — | — | +54.2% | +85.6% | +67.0% | +38.9% | +58.2% | +75.1% |
| % of Inventories | 14.0% | 11.6% | 12.7% | 15.1% | 16.2% | 14.0% | 12.3% | 12.7% | 14.1% | 15.7% |
| Share Change | — | -2.3pp | +1.0pp | +2.4pp | +1.1pp | -2.2pp | -1.7pp | +0.4pp | +1.4pp | +1.6pp |
Range$699.60M – $2.27B
CAGR+59.8%
Avg YoY Growth+63.2%
Median YoY Growth+62.6%
Current Streak8 quarters growth
Finished goods at Other Companies
Frequently Asked Questions
- What is Eli Lilly's finished goods?
- Eli Lilly (LLY) reported finished goods of $2.27B in Q1 2026.
- How has Eli Lilly's finished goods changed year-over-year?
- Eli Lilly's finished goods increased by 75.1% year-over-year, from $1.30B to $2.27B.
- What is the long-term trend for Eli Lilly's finished goods?
- Over 2 years (2023 to 2025), Eli Lilly's finished goods has grown at a 56.2% compound annual growth rate (CAGR), from $791.70M to $1.93B.
- What does finished goods mean?
- The value of completed products ready for sale.